(0.04%) 5 013.30 points
(0.47%) 37 953 points
(-0.40%) 15 539 points
(-0.17%) $82.59
(2.62%) $1.803
(-0.05%) $2 396.80
(0.28%) $28.46
(-1.48%) $940.40
(-0.18%) $0.938
(-0.25%) $11.01
(-0.16%) $0.803
(-0.83%) $93.12
Live Chart Being Loaded With Signals
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes...
Stats | |
---|---|
Today's Volume | 64 215.00 |
Average Volume | 98 131.00 |
Market Cap | 0.00 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -15.60 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-07-29 | Loconti Joseph E. | Buy | 1 000 | Common Stock, par value $0.001 per share |
2021-07-20 | Loconti Joseph E. | Buy | 13 000 | Common Stock, par value $0.001 per share |
2021-07-19 | Loconti Joseph E. | Buy | 20 000 | Common Stock, par value $0.001 per share |
2021-07-19 | Loconti Joseph E. | Buy | 67 000 | Common Stock, par value $0.001 per share |
2021-07-19 | Loconti Joseph E. | Buy | 40 000 | Common Stock, par value $0.001 per share |
INSIDER POWER |
---|
0.00 |
Last 43 transactions |
Buy: 13 752 971 | Sell: 3 655 234 |
Vitality Biopharma, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vitality Biopharma, Inc. Financials
Annual | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.0200 |
Q2 | 2022 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.0100 |
Q1 | 2022 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.0100 |
Q4 | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.00709 |
Financial Reports:
No articles found.
Vitality Biopharma, Inc.
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators